Podcast Episodes
Back to SearchBio Career Moves with Codagenix's Johanna Kaufmann, Ph.D.
We love to hear from our listeners. Send us a message.
Johanna Kaufmann, Ph.D.'s path to EVP, Oncology at Codagenix is part serendipity and part circ…
2 years, 3 months ago
Veteran Advice From The C-Suite with Citius' Leonard Mazur
We love to hear from our listeners. Send us a message.
On this episode of the Business of Biotech, Leonard Mazur, co-founder, CEO, and chairman of Ci…
2 years, 3 months ago
Don't Be A D**k with Ochre Bio's Quin Wills, M.D., Ph.D.
We love to hear from our listeners. Send us a message.
Don't be offended by the title of today's Business of Biotech podcast. Dr. Quin Wills' applica…
2 years, 3 months ago
Pragmatic Computational Biology with Andrew Satz
We love to hear from our listeners. Send us a message.
This week's guest on the Business of Biotech, EVQLV's Andrew Satz, says AI and ML in biopharma…
2 years, 3 months ago
Commercial Readiness with Orca Bio's Dan Kirby
We love to hear from our listeners. Send us a message.
Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeut…
2 years, 4 months ago
Bio & The Business Of Aging with Life Biosciences' Jerry McLaughlin
We love to hear from our listeners. Send us a message.
Core to the clinical-stage biopharma Life Bisociences belief set is that, "contrary to popular…
2 years, 4 months ago
Fiscal Turnarounds with Protalix's Eyal Rubin
We love to hear from our listeners. Send us a message.
Within about five minutes of conversation with Protalix CFO Eyal Rubin, I learned that he does…
2 years, 4 months ago
Building LEO Pharma's U.S. Presence with Brian Hilberdink
We love to hear from our listeners. Send us a message.
In many respects, bringing an established foreign biopharma company to the U.S. market is not …
2 years, 4 months ago
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
We love to hear from our listeners. Send us a message.
Since we last spoke in the Spring of 2021, Nevan Charles Elam, JD has managed to advance both …
2 years, 4 months ago
Facing NASH Therapeutic Skepticism with 89bio's Rohan Palekar
We love to hear from our listeners. Send us a message.
The non-alcoholic steatohepatitis (NASH) therapeutics market has proven to be an 11/10 on the …
2 years, 5 months ago